Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126160931 | 12616093 | 1 | I | 20160715 | 20160729 | 20160802 | 20160802 | EXP | GB-MHRA-EYC 00142927 | GB-ELI_LILLY_AND_COMPANY-GB201607013515 | ELI LILLY AND CO | 0.00 | M | Y | 143.00000 | KG | 20160801 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126160931 | 12616093 | 1 | PS | OLANZAPINE. | OLANZAPINE | 1 | Oral | 5 MG, UNKNOWN | N | U | 20592 | 5 | MG | ||||||
| 126160931 | 12616093 | 2 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | 1 DF, UNKNOWN | U | 0 | 1 | DF | |||||||
| 126160931 | 12616093 | 3 | C | INDAPAMIDE. | INDAPAMIDE | 1 | Unknown | 1 DF, UNKNOWN | U | 0 | 1 | DF | |||||||
| 126160931 | 12616093 | 4 | C | LISINOPRIL. | LISINOPRIL | 1 | Unknown | 1 DF, UNKNOWN | U | 0 | 1 | DF | |||||||
| 126160931 | 12616093 | 5 | C | TRAMADOL. | TRAMADOL | 1 | Unknown | 1 DF, UNKNOWN | U | 0 | 1 | DF | |||||||
| 126160931 | 12616093 | 6 | C | ZOPICLONE | ZOPICLONE | 1 | Unknown | 1 DF, UNKNOWN | U | 0 | 1 | DF |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126160931 | 12616093 | 1 | Mental disorder |
| 126160931 | 12616093 | 2 | Product used for unknown indication |
| 126160931 | 12616093 | 3 | Product used for unknown indication |
| 126160931 | 12616093 | 4 | Product used for unknown indication |
| 126160931 | 12616093 | 5 | Product used for unknown indication |
| 126160931 | 12616093 | 6 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126160931 | 12616093 | HO |
| 126160931 | 12616093 | DS |
| 126160931 | 12616093 | LT |
| 126160931 | 12616093 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126160931 | 12616093 | Blood triglycerides increased | |
| 126160931 | 12616093 | Diarrhoea | |
| 126160931 | 12616093 | Electrocardiogram QT prolonged | |
| 126160931 | 12616093 | General physical health deterioration | |
| 126160931 | 12616093 | Hyperosmolar hyperglycaemic state | |
| 126160931 | 12616093 | Hypotension | |
| 126160931 | 12616093 | Malaise | |
| 126160931 | 12616093 | Neuroleptic malignant syndrome | |
| 126160931 | 12616093 | Polydipsia | |
| 126160931 | 12616093 | Polyuria | |
| 126160931 | 12616093 | Renal failure | |
| 126160931 | 12616093 | Tachypnoea | |
| 126160931 | 12616093 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126160931 | 12616093 | 1 | 20160712 | 20160719 | 0 |